Mabel Jouve
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Endocrinology top 1%
- Escherichia coli research studies
Papers in
- Virology 13
- HIV Research and Treatment 13
-
- Escherichia coli research studies 9
- Co-authors
- Clotilde ThéryDamarys LoewFlorent DingliMercedes TkachJoanna KowalBjarke Primdal-BengtsonMarina ColomboGuillaume Arras
- Journals
- Cell (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Microbiology (3 papers)Journal of Extracellular Vesicles (3 papers)The EMBO Journal (3 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Mabel Jouve
48 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.8k
- Endocrinology 485
- Virology 427
- Aging 147
- Immunology 1.5k
Countries citing papers authored by Mabel Jouve
This map shows the geographic impact of Mabel Jouve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Jouve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Jouve more than expected).
Fields of papers citing papers by Mabel Jouve
This network shows the impact of papers produced by Mabel Jouve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Jouve. The network helps show where Mabel Jouve may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Jouve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 21 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 83 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 13 | |
| 6 | Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9 Hit paper breakdown → | 2021 | 569 |
| 7 | 2021 | 9 | |
| 8 | 2020 | 87 | |
| 9 | 2019 | 27 | |
| 10 | 2019 | 42 | |
| 11 | 2018 | 167 | |
| 12 | 2017 | 292 | |
| 13 | 2017 | 14 | |
| 14 | Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes Hit paper breakdown → | 2016 | 2625 |
| 15 | 2016 | 26 | |
| 16 | 2015 | 148 | |
| 17 | 2010 | 65 | |
| 18 | 2007 | 0 | |
| 19 | 2003 | 71 | |
| 20 | 2000 | 40 |
About Mabel Jouve
Mabel Jouve is a scholar working on Virology, Endocrinology, Molecular Medicine, Immunology and Infectious Diseases, having authored 49 papers that have together received 5.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (13 papers), Extracellular vesicles in disease (11 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (9 papers), Escherichia coli research studies (9 papers), Antibiotic Resistance in Bacteria (6 papers), T-cell and B-cell Immunology (5 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Cancer Research (1.8k citations), Endocrinology (485 citations), Virology (427 citations), Aging (147 citations) and Immunology (1.5k citations). Mabel Jouve has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Clotilde Théry, Damarys Loew, Florent Dingli, Mercedes Tkach, Joanna Kowal, Bjarke Primdal-Bengtson, Marina Colombo, Guillaume Arras, Philippe Benaroch and Danielle Lankar. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences, Journal of Clinical Microbiology, Journal of Extracellular Vesicles and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.